| Factor | Score | Distribution | Value | Avg | Rank |
|---|---|---|---|---|---|
Valuation | 67 | 47.1x | 17.8x | Top tier | |
Growth | 21 | 1.6% | 7.1% | Bottom tier | |
Quality | 82 | 12.8% | 4.5% | Top tier | |
Safety | 40 | 5.1x | 2.6x | Bottom tier | |
Capital Return | 37 | 4.68% | 2.12% | Bottom tier | |
Momentum | 36 | 6.3% | 2.9% | Bottom tier | |
Sentiment | 39 | 6 | 3 | Bottom tier |
Estimates — analyst targets and a simplified DCF, not investment advice.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.
The Scotts Miracle-Gro Company operates in lawn and garden care and pest control products, generating revenue from a portfolio of brands such as Scotts, Miracle-Gro, Ortho, and Roundup, alongside soil, seed, and fertilizer products. The SMG 2.0 strategy focuses on increasing the share of branded, higher-margin products, accelerating innovation, expanding e-commerce, eliminating underperforming units, and achieving savings through automation and artificial intelligence.
In Q3 fiscal 2026, according to EDGAR data, the company reported revenue of $1.2 billion, gross profit of $365.9 million, net income of $112.2 million, and earnings per share of $1.90. These figures equate to a gross margin of approximately 30.5% and a net income margin of approximately 9.4%, while the July 29, 2026 call clarified that exact net sales were $1.17 billion, up 1% year over year, and that the GAAP gross margin was 31.2% versus 32.1% in the comparable quarter.
During the first nine months of fiscal 2026, the company's revenue increased 2% to $2.99 billion, with the U.S. Consumer business contributing approximately $2.74 billion, or nearly 92% of the total. Revenue for the twelve months ended Q3 fiscal 2026 was approximately $3.4 billion, with gross profit of $1.1 billion and net income of $110.8 million; the difference between annual net income and the strong profit in Q2 and Q3 highlights the seasonality of the business and the impact of the $125 million loss in Q1 fiscal 2026.
Automated analysis for informational purposes only — not investment advice.
The analyst consensus rates SMG shares a "Buy," with an average target of $77.25 and a narrow range between $75 and $79; the average is approximately 2.5% above the upper end of the 52-week range of $75.34, while the lower end of the range is $52. The data does not provide a published price-to-earnings ratio that can be reliably used, so the consensus valuation is based on improvements in adjusted earnings and margins and reduced leverage, balanced against slow revenue growth, pressure from freight and commodity costs, and the delayed timeline for long-term targets.
Figures in the text are as of 2026-08-31; the live price is shown at the top of the page.
According to EDGAR, the company reported revenue of $1.2 billion, gross profit of $365.9 million, and net income of $112.2 million in Q3 fiscal 2026. The July 29, 2026 call clarified that net sales grew 1% to $1.17 billion, supported by an increase in branded products. In contrast, freight and commodity costs reduced the GAAP gross margin to 31.2% from 32.1%, and adjusted earnings before interest, taxes, depreciation, and amortization declined to $246.3 million.
SMG 2.0 relies on optimizing the product portfolio, accelerating innovation, expanding e-commerce, and increasing efficiency through technology, automation, and artificial intelligence. In fiscal 2026, the company exited approximately $100 million of low-margin commodity mulch and soil sales and is targeting the elimination of approximately 30% of the lowest-performing units by the end of fiscal 2027, having completed nearly two-thirds of this target as of July 29, 2026. Fiscal 2026 innovations, including Scotts Kentucky 31, Turf Builder Lawn Food, and Ortho Mosquito Kill and Prevent, generated gross sales of $75 million before accounting for cannibalization of existing products.
E-commerce point-of-sale sales increased 27% during the first nine months of fiscal 2026, with growth in every category and across every customer included in the company's data. E-commerce came to represent 13% of total point-of-sale sales, up 300 basis points from the prior year. The company uses the channel to launch products such as Ortho Mosquito Kill and Prevent and test demand digitally before expanding distribution in retail stores.
The company entered Q4 fiscal 2026 with retailer inventories up by a high-single-digit percentage from the prior year, following weather-related weakness in May 2026, and therefore expected purchases to slow. The projected increase in commodity costs above the original plan also reached approximately $15 million for fiscal 2026, most of which appeared in Q3. Despite hedging and securing most of the cost of goods through the end of fiscal 2026, diesel and freight costs and pricing discussions with retailers remained important factors for the fiscal 2027 plan.
Adjusted net income from continuing operations was $390.2 million, or $6.60 per share, during the first nine months of fiscal 2026, versus $336.9 million and $5.75 per share in the comparable period. The company raised its fiscal 2026 adjusted earnings per share guidance to $4.30–$4.45 from $4.15–$4.35. Leverage in Q3 fiscal 2026 also declined to 3.78 times from 4.15 times a year earlier, and year-to-date interest expense fell to $86.5 million from $102.2 million.
The analyst consensus rates the shares a "Buy," with an average target of $77.25 and targets ranging between $75 and $79. The average target is approximately 2.5% above the top of the 52-week range of $75.34, and the data does not include a published price-to-earnings ratio to provide an additional valuation anchor. Regarding insiders, net sales totaled $2.2 million across four transactions during the three months ended August 10, 2026, with no purchases, but these sales may have been prearranged and are not sufficient on their own to form an investment judgment.
